# Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns

> **NCT01605279** · PHASE2 · COMPLETED · sponsor: **Adelina Pellicer** · enrollment: 127 (actual)

## Conditions studied

- Hemodynamic Instability

## Interventions

- **DRUG:** Dobutamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01605279
- **Lead sponsor:** Adelina Pellicer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2015-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01605279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01605279, "Dobutamine Versus Placebo for Low Superior Vena Cava Flow in Newborns". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01605279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*